Brachkova et al., 2009 - Google Patents
Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage formsBrachkova et al., 2009
View HTML- Document ID
- 2415284558429486279
- Author
- Brachkova M
- Duarte A
- Pinto J
- Publication year
- Publication venue
- Journal of Pharmaceutical sciences
External Links
Snippet
The work aims to provide evidence on the viability of Lactobacillus spp. and a spore form of Bacillus subtilis from nonprocessed bacteria to coated dosage forms (ie, mini-tablets, pellets, and their coated forms). Lactobacillus spp. were cultivated overnight in MRS broth (10 9 …
- 230000035899 viability 0 title abstract description 60
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050266069A1 (en) | Stable probiotic microsphere compositions and their methods of preparation | |
| CA2825473C (en) | Protection of microbial cells from acidic degradation | |
| Poulin et al. | β-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria | |
| Kanmani et al. | Effect of cryopreservation and microencapsulation of lactic acid bacterium Enterococcus faecium MC13 for long-term storage | |
| AU2016365214B2 (en) | Stable dry compositions having no or little sugars | |
| RU2560425C2 (en) | Stabiliser of colour in bacterial composition | |
| BE1024197B1 (en) | Process for coating microorganisms, powder of said coated microorganisms obtained and pharmaceutical, nutraceutical, cosmetic, food or sanitary composition comprising it. | |
| Sarkar | Approaches for enhancing the viability of probiotics: a review | |
| WO2009061222A2 (en) | Stabilisation of dried biological material | |
| JP2019522641A (en) | Method for producing bacterial composition | |
| US20170304374A1 (en) | Capsule for the oral administration of biopharmaceuticals | |
| Wang et al. | Drying of probiotics to enhance the viability during preparation, storage, food application, and digestion: A review | |
| Brachkova et al. | Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms | |
| Brachkova et al. | Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads | |
| CN116096856A (en) | Microencapsulated microbial cultures utilizing octenyl succinic anhydride starch-chitosan complex agglomerates | |
| Harel et al. | Protection and delivery of probiotics for use in foods | |
| WO2015140299A1 (en) | Oronasopharyngeal probiotics | |
| Azim et al. | Effect of heat, pH and coating process with stearic acid using a fluidized bed granulator on viability of probiotic Lactobacillus reuteri C 10 | |
| Bora et al. | Physicochemical properties and excipient compatibility studies of probiotic Bacillus coagulans spores | |
| Zimmermann et al. | Macroencapsulation of Limosilactobacillus reuteri DSPV002C as nutritional supplement for piglets: Storage stability and survival in gastrointestinal conditions | |
| WO2020189228A1 (en) | Enhancer of beneficial intestinal bacteria growth and organic acid production | |
| Huckle et al. | Maintenance and protection of probiotics | |
| Paliy et al. | Development of technical regulations for the capsulated probiotic manufacture | |
| Ouwehand et al. | Probiotics: from strain to product | |
| Amaral et al. | Development of Probiotic Dosage Forms |